MP

Mehul Pravin Shah

Active Director Director DIN 02657748
DIN 02657748 First appointment Apr 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 11 active board seats
Past companies 8 historical roles
Total affiliations 19 Since Apr 2005
Shareholding value •••• Premium profile

About Mehul Pravin Shah

Data last updated:

Mehul Pravin Shah is a Director at Precise Biopharma Private Limited (since 2005), Director at Precise Chemipharma P Ltd (since 2024) and Director at Blisson Mediplus Private Limited (since 2013), and holds 8 more current directorships. The companies operate in Pharma, Healthcare and Travel and Hospitality. The 6 current companies with reported revenue have a combined latest revenue of ₹346 Cr; the largest is Precise Biopharma Private Limited at ₹201 Cr (FY 2025). Earlier, Mehul Pravin Shah was a Designated Partner at Embrion Art Surat Llp (2017–2024) and Director at Bioaltus Pharmaceuticals Private Limited (2021–2022) and 6 more.

DIN 02657748
Primary Designation Director
Industry Pharma
First Appointment 06 Apr 2005
Oldest Company Age 32 yrs
Largest company Precise Biopharma Private Limited · ₹201 Cr (FY 2025)
Combined revenue ₹346 Cr across 6 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Precise Biopharma Private Limited U24230MH2005PTC152453
Director06 Apr 20052005₹201 Cr (FY 2025)Active
Precise Chemipharma P Ltd U24110MH1993PTC075033
Director01 Jun 20241993₹48.20 Cr (FY 2025)Active
Blisson Mediplus Private Limited U11100MH2013PTC244233
Director10 Jun 20132013₹44.12 Cr (FY 2024)Active
Blisson Medica Private Limited U24290MH2019PTC325171
Director09 May 20192019₹43.99 Cr (FY 2024)Active
Cyrus Remedies Private Limited U24110MH2021PTC365048
Director02 Aug 20212021₹8.41 Cr (FY 2024)Active
Suremed Lifecare Private Limited U85191MH2011PTC216142
Director16 Jan 20142011₹19.4 Lakh (FY 2025)Active
Bmedica One Llp ACS-5567
Designated Partner10 Nov 20252025Active
Designated Partner06 Aug 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner05 Jun 20172017Active
Director15 Jan 20212014₹118 Cr (FY 2025)Active
Director16 Feb 20162016₹94 Lakh (FY 2025)Active
Priserve Infratech Limited U72300MH2013PLC239560
Director11 Jan 20132013Strike Off
Embrion Art Private Limited U85300GJ2017PTC096747
Director07 Apr 20172017₹45.4 Lakh (FY 2025)Active
Construee Solutions Private Limited U74999MH2011PTC217269
Director10 May 20112011Active
Swasth Edible Oils Limited U15400MH2012PLC236904
Director17 Oct 20122012Strike Off
Cenesys Care India Private Limited U24100TN2013PTC089301
Director08 Jan 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Blisson Mediplus Private Limited
Swasth Edible Oils Limited
Cenesys Care India Private Limited
Cyrus Remedies Private Limited
Premium access

Shareholding and investment profile for Mehul Pravin Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mehul Pravin Shah

Mehul Pravin Shah currently holds 11 directorships: Precise Biopharma Private Limited (Director, since 06 Apr 2005, revenue ₹201 Cr (FY 2025)); Precise Chemipharma P Ltd (Director, since 01 Jun 2024, revenue ₹48.20 Cr (FY 2025)); Blisson Mediplus Private Limited (Director, since 10 Jun 2013, revenue ₹44.12 Cr (FY 2024)); Blisson Medica Private Limited (Director, since 09 May 2019, revenue ₹43.99 Cr (FY 2024)); Cyrus Remedies Private Limited (Director, since 02 Aug 2021, revenue ₹8.41 Cr (FY 2024)); and 6 more.

Mehul Pravin Shah was first appointed on 06 Apr 2005 as Director at Precise Biopharma Private Limited. The most recent appointment on record is 10 Nov 2025 at Bmedica One Llp.

The 6 current companies of Mehul Pravin Shah that report revenue have a combined latest revenue of ₹346 Cr: Precise Biopharma Private Limited ₹201 Cr (FY 2025); Precise Chemipharma P Ltd ₹48.20 Cr (FY 2025); Blisson Mediplus Private Limited ₹44.12 Cr (FY 2024); Blisson Medica Private Limited ₹43.99 Cr (FY 2024); Cyrus Remedies Private Limited ₹8.41 Cr (FY 2024); and 1 more.

Mehul Pravin Shah held 8 earlier board appointments: Embrion Art Surat Llp (Designated Partner, 05 Jun 2017 to 19 Apr 2024); Bioaltus Pharmaceuticals Private Limited (Director, 15 Jan 2021 to 25 Aug 2022); Stembrella Precise Healthcare Private Limited (Director, 16 Feb 2016 to 04 Nov 2019); Priserve Infratech Limited (Director, 11 Jan 2013 to 28 Mar 2018); Embrion Art Private Limited (Director, 07 Apr 2017 to 22 Mar 2022); and 3 more.

The current boards of Mehul Pravin Shah's companies include Rachana Mehul Shah (Precise Biopharma Private Limited), Sunil Sadanand Sukhathankar (Precise Biopharma Private Limited), Gauri Pranay Shah (Precise Chemipharma P Ltd), Pranay Pravin Shah (Precise Chemipharma P Ltd), Subhendu Chattopadhyay (Blisson Mediplus Private Limited), Tushar Madhukar Patil (Blisson Mediplus Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available